Efficacy and safety of once-weekly Semaglutide for weight management in adults with overweight or obesity with or without type 2 diabetes: A real-world clinical trial in Bangladesh
Introduction: Semaglutide has shown substantial weight reduction in trials, but real-world evidence from South Asian populations is scarce. We evaluated the efficacy and safety of once-weekly semaglutide 2·4 mg over 26 weeks in adults with overweight or obesity, with and without type 2 diabetes mellitus (T2DM). Methods...